Engineering a probiotic strain of Escherichia coli to induce the regression of colorectal cancer through production of 5‐aminolevulinic acid-Reference-Cited by-同舟云学术

Engineering a probiotic strain of Escherichia coli to induce the regression of colorectal cancer through production of 5‐aminolevulinic acid

Published:2021-07-16 Issue:5 Volume:14 Page:2130-2139
ISSN:1751-7915
Container-title:Microbial Biotechnology
language:en
Short-container-title:Microb. Biotechnol.

Author:

Chen Junhao¹,Li Xiaohong¹,Liu Yumei¹,Su Tianyuan²,Lin Changsen³,Shao Lijun¹,Li Lanhua¹,Li Wanwei¹,Niu Guoyu¹,Yu Jing³,Liu Ling¹,Li Miaomiao¹,Yu Xiaoli¹^ORCID,Wang Qian²

Affiliation:

1. School of Public Health Weifang Medical University Weifang, Shandong 261053 China

2. State Key Laboratory of Microbial Technology National Glycoengineering Research Center Shandong University Qingdao, Shandong 266237 China

3. Affiliated Hospital of Shandong University of Traditional Chinese Medicine Jinan, Shandong 250014 China

Publisher

Wiley

Subject

Applied Microbiology and Biotechnology,Biochemistry,Bioengineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1751-7915.13894

Reference34 articles.

1. Bacteriolytic therapy can generate a potent immune response against experimental tumors

2. Effects of levulinic acid on 5-aminolevulinic acid production in heterotrophic cultures of Chlorella regularis YA-603

3. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

4. Programmable bacteria induce durable tumor regression and systemic antitumor immunity

5. Designer probiotics for the prevention and treatment of human diseases

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering probiotic Escherichia coli Nissle 1917 to block transfer of multiple antibiotic resistance genes by exploiting a type I CRISPR-Cas system;Applied and Environmental Microbiology;2024-09-10

2. Towards Understanding Tumour Colonisation by Probiotic Bacterium E. coli Nissle 1917;Cancers;2024-08-26

3. Non-native Pathway Engineering with CRISPRi for Carbon Dioxide Assimilation and Valued 5-Aminolevulinic Acid Synthesis in Escherichia coli Nissle;ACS Synthetic Biology;2024-07-02

4. Modularized Engineering of Shewanella oneidensis MR-1 for Efficient and Directional Synthesis of 5-Aminolevulinic Acid;Metabolic Engineering;2024-05

5. Engineering probioticEscherichia coliNissle 1917 to block transfer of multiple antibiotic resistance genes by exploiting a type I CRISPR-Cas system;2024-04-02